Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C15H12O3 |
| Molecular Weight | 240.254 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=CC=C(C=C1)C2CC(=O)C3=CC=CC=C3O2
InChI
InChIKey=ZLHVIYHWWQYJID-UHFFFAOYSA-N
InChI=1S/C15H12O3/c16-11-7-5-10(6-8-11)15-9-13(17)12-3-1-2-4-14(12)18-15/h1-8,15-16H,9H2
| Molecular Formula | C15H12O3 |
| Molecular Weight | 240.254 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
DescriptionSources: https://www.drugbank.ca/drugs/DB04429Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/17685652 | https://www.ncbi.nlm.nih.gov/pubmed/22634867
Sources: https://www.drugbank.ca/drugs/DB04429
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/17685652 | https://www.ncbi.nlm.nih.gov/pubmed/22634867
4’-Hydroxyflavanone is a flavonoid that can be found naturally in parsley, onions, berries, tea, and citrus fruits. 4-Hydroxyflavanone is an inhibitor of SREBP maturation and lipid synthesis, and 4-Hydroxyflavanone may have major potential as a pharmaceutical preparation against hepatic steatosis and dyslipidemia.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL237 Sources: https://www.ncbi.nlm.nih.gov/pubmed/17685652 |
|||
Target ID: CHEMBL236 Sources: https://www.ncbi.nlm.nih.gov/pubmed/17685652 |
|||
Target ID: CHEMBL233 Sources: https://www.ncbi.nlm.nih.gov/pubmed/17685652 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Human sex hormone-binding globulin binding affinities of 125 structurally diverse chemicals and comparison with their binding to androgen receptor, estrogen receptor, and α-fetoprotein. | 2015-02 |
|
| Rat α-Fetoprotein binding affinities of a large set of structurally diverse chemicals elucidated the relationships between structures and binding affinities. | 2012-11-19 |
|
| An efficient HPLC method for the quantification of isoflavones in soy extracts and soy dietary supplements in routine quality control. | 2006-07 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.drugbank.ca/drugs/DB04429
Rat acute toxicity (LD50) 2.8753 mol/kg
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/17685652
Test compounds (4-Hydroxyflavanone) were first assayed at 10 mkM for intrinsic activity using the [35S]GTP-gamma-S binding assay and CHO cell membrane homogenates that express the human muOR, deltaOR, or kappaOR. The subtype selective agonists (D-Ala2,MePhe4,Gly-ol5)enkephalin (DAMGO, muOR), (D-Pen2,D-Pen5)enkephalin (DPDPE, deltaOR), or U69,593 (kappaOR) were run as positive controls as appropriate. The CHO membranes were incubated in duplicate in 1.4 mL polypropylene tubes (Matrix Technologies, Hudson, NH) with positive control or test compound, 0.1 nM [35S]GTP-gamma-S, and 1 mkM GDP in 50 mM HEPES buffer (pH 7.4) at room temperature for 1 h, after which bound radioligand was separated from free via rapid vacuum filtration over GF-B filters with a Brandel Scientific (Gaithersburg, MD) 96-well harvester. Bound radioactivity was determined using a TopCount 12-detector instrument (Packard Instruments) using standard scintillation counting techniques. The data were normalized to samples containing vehicle (basal binding).
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 20:38:47 GMT 2025
by
admin
on
Mon Mar 31 20:38:47 GMT 2025
|
| Record UNII |
5K6L8O868Y
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
6515-37-3
Created by
admin on Mon Mar 31 20:38:47 GMT 2025 , Edited by admin on Mon Mar 31 20:38:47 GMT 2025
|
PRIMARY | |||
|
C561123
Created by
admin on Mon Mar 31 20:38:47 GMT 2025 , Edited by admin on Mon Mar 31 20:38:47 GMT 2025
|
PRIMARY | |||
|
5K6L8O868Y
Created by
admin on Mon Mar 31 20:38:47 GMT 2025 , Edited by admin on Mon Mar 31 20:38:47 GMT 2025
|
PRIMARY | |||
|
34361
Created by
admin on Mon Mar 31 20:38:47 GMT 2025 , Edited by admin on Mon Mar 31 20:38:47 GMT 2025
|
PRIMARY | |||
|
DTXSID5022487
Created by
admin on Mon Mar 31 20:38:47 GMT 2025 , Edited by admin on Mon Mar 31 20:38:47 GMT 2025
|
PRIMARY | |||
|
165506
Created by
admin on Mon Mar 31 20:38:47 GMT 2025 , Edited by admin on Mon Mar 31 20:38:47 GMT 2025
|
PRIMARY | |||
|
41965
Created by
admin on Mon Mar 31 20:38:47 GMT 2025 , Edited by admin on Mon Mar 31 20:38:47 GMT 2025
|
PRIMARY | |||
|
DB04429
Created by
admin on Mon Mar 31 20:38:47 GMT 2025 , Edited by admin on Mon Mar 31 20:38:47 GMT 2025
|
PRIMARY |